Another circUBR5 was recently reported (2024) to promote ribosome biogenesis and docetaxel resistance in triple-negative breast cancer via the miR-340-5p/CMTM6/c-MYC axis [34]. Here, MYC is linked to triple-negative breast carcinoma.